GGrantIndex
Sort

21,453 grants matching tuberculosis

GLYCOSYLTRANSFERASES AS DRUG TARGETS IN MYCOBACTERIA

$420,267
Southern Research Institute · R01 · FY2001 · AI

Mycobacterial trehalose metabolism as drug targets

$420,179
Donald R Ronning · University Of Nebraska Medical Center · R01 · FY2021 · AI

Multidisciplinary AIDS Training Program

$420,102
Daniel R Kuritzkes · Brigham And Women'S Hospital · T32 · FY2021 · AI

Preclinical Diagnostic Imaging of Amyloid

$420,101
Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2011 · DK

Virulence Related Genetic Variation of M Tb Strains

$420,094
University Of Michigan At Ann Arbor · R01 · FY2001 · AI

Chemoenzymatic Synthesis of Trehalose Analogs as Tools for Investigating Mycobacteria

$420,085
Benjamin Michael Swarts · Central Michigan University · R15 · FY2015 · AI

Elucidating physiology of dormant bacteria to combat antibiotic persistence

$419,863
Markus Thomas Basan · Harvard Medical School · R35 · FY2022 · GM

Structure biology of Mycobacterium tuberculosis Pup-proteasome pathway

$419,833
Huilin Li · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2013 · AI

Core D: Clinical Sciences

$419,795
Jeffrey M Jacobson · Case Western Reserve University · P30 · FY2024 · AI

Basic Mechanisms in Lung Disease

$419,788
University Of Alabama At Birmingham · T32 · FY2004 · HL

CORE 2: Technology Core

$419,748
Alexander Marson · University Of California, San Francisco · U19 · FY2020 · AI

Generation and persistence of CD4 memory subsets

$419,678
Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI

Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria

$419,611
Dean C Crick · Colorado State University · R01 · FY2017 · AI

FcR Deficient Mice Susceptibility to Pathogens

$419,513
Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2012 · AI

FcR Deficient Mice Susceptibility to Pathogens

$419,513
Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2011 · AI

Novel disposable microchips for HIV-1 viral load

$419,475
Utkan Demirci · Brigham And Women'S Hospital · R01 · FY2013 · AI

Pyrazinamide and Trans-Translation in Mycobacterium tuberculosis

$419,428
Ying Zhang · Johns Hopkins University · R01 · FY2015 · AI

Molecular Genetic Analysis of Mycobacterium tuberculosis

$419,399
William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2008 · AI

Research Training in Infectious Diseases

$419,373
Roy M Gulick · Weill Medical Coll Of Cornell Univ · T32 · FY2023 · AI

Development of Aersolized Vaccines

$419,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Development of Aersolized Vaccines

$419,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Development of Aersolized Vaccines

$419,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Development of Aersolized Vaccines

$419,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

PROTEASOMAL REGULATION AND PROTEIN QUALITY CONTROL IN M. TUBERCULOSIS

$419,333
Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2021 · AI

Development of new furanyl anti-tuberculosis inhibitors

$419,298
University Of Tennessee Health Sci Ctr · R01 · FY2005 · AI